| Primary |
| Ill-defined Disorder |
31.3% |
| Product Used For Unknown Indication |
30.9% |
| Drug Use For Unknown Indication |
13.4% |
| Hypertension |
13.2% |
| Maternal Exposure Timing Unspecified |
2.6% |
| Essential Hypertension |
2.3% |
| Hiv Infection |
1.2% |
| Colorectal Cancer |
0.8% |
| Myocardial Ischaemia |
0.7% |
| Prophylaxis |
0.5% |
| Atrial Fibrillation |
0.4% |
| Cardiovascular Event Prophylaxis |
0.4% |
| Nephropathy |
0.4% |
| Type 2 Diabetes Mellitus |
0.4% |
| Cerebrovascular Accident Prophylaxis |
0.3% |
| Coronary Artery Disease |
0.3% |
| Hypercholesterolaemia |
0.3% |
| Myocardial Infarction |
0.3% |
| Schizophrenia |
0.3% |
| Arrhythmia |
0.2% |
|
| Renal Failure Acute |
12.4% |
| Drug Interaction |
7.9% |
| Syncope |
7.9% |
| Dizziness |
5.6% |
| Drug Ineffective |
5.6% |
| Paraesthesia |
5.6% |
| Vomiting |
5.6% |
| Infertility Male |
4.5% |
| Interstitial Lung Disease |
4.5% |
| Renal Aplasia |
4.5% |
| Renal Failure |
4.5% |
| Swollen Tongue |
4.5% |
| Angioedema |
3.4% |
| Blood Pressure Increased |
3.4% |
| Coronary Artery Disease |
3.4% |
| Foetal Exposure During Pregnancy |
3.4% |
| Hyperkalaemia |
3.4% |
| Hyponatraemia |
3.4% |
| Malaise |
3.4% |
| Myocardial Infarction |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
27.9% |
| Hypertension |
20.9% |
| Drug Use For Unknown Indication |
18.5% |
| Type 2 Diabetes Mellitus |
3.4% |
| Schizophrenia |
3.2% |
| Ill-defined Disorder |
3.1% |
| Urinary Tract Infection |
2.7% |
| Cardiac Failure |
2.7% |
| Renal Transplant |
2.2% |
| Prophylaxis |
1.8% |
| Congestive Cardiomyopathy |
1.8% |
| Depression |
1.5% |
| Essential Hypertension |
1.4% |
| Drug Exposure During Pregnancy |
1.3% |
| Atrial Fibrillation |
1.3% |
| Hepatitis B |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Intentional Overdose |
1.3% |
| Myocardial Infarction |
1.2% |
| Myocardial Ischaemia |
1.2% |
|
| Renal Failure Acute |
16.5% |
| Thrombocytopenia |
8.0% |
| Spermatozoa Progressive Motility Decreased |
6.8% |
| Ventricular Tachycardia |
6.8% |
| Paraesthesia |
6.3% |
| Weight Decreased |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Hypertension |
4.2% |
| Renal Failure |
4.2% |
| Pemphigoid |
3.8% |
| Spermatozoa Progressive Motility Abnormal |
3.8% |
| Urinary Tract Infection |
3.8% |
| Vomiting |
3.8% |
| Angioedema |
3.4% |
| Dizziness |
3.4% |
| Fall |
3.4% |
| Interstitial Lung Disease |
3.0% |
| Leukopenia |
3.0% |
| Pruritus |
3.0% |
| Ventricular Fibrillation |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Drug Use For Unknown Indication |
19.4% |
| Hypertension |
16.1% |
| Atrial Fibrillation |
5.4% |
| Rheumatoid Arthritis |
4.5% |
| Prophylaxis |
3.6% |
| Diabetes Mellitus |
3.2% |
| Pain |
2.7% |
| Cardiac Failure |
2.5% |
| Diffuse Large B-cell Lymphoma |
2.4% |
| Depression |
2.3% |
| Type 2 Diabetes Mellitus |
2.0% |
| Osteoporosis |
2.0% |
| Hiv Infection |
2.0% |
| Multiple Myeloma |
1.9% |
| Hypercholesterolaemia |
1.8% |
| Thrombosis Prophylaxis |
1.6% |
| Acute Myocardial Infarction |
1.3% |
| Hyperlipidaemia |
1.2% |
| Myocardial Infarction |
1.2% |
|
| Vomiting |
10.6% |
| Renal Failure |
8.6% |
| Myocardial Infarction |
7.1% |
| Death |
6.4% |
| Weight Decreased |
6.1% |
| Renal Failure Acute |
6.0% |
| Thrombocytopenia |
5.8% |
| Malaise |
5.6% |
| Pyrexia |
4.2% |
| Rhabdomyolysis |
4.2% |
| Transient Ischaemic Attack |
4.0% |
| Renal Impairment |
3.8% |
| Pruritus |
3.6% |
| Syncope |
3.6% |
| Tremor |
3.6% |
| Cerebrovascular Accident |
3.5% |
| Nausea |
3.5% |
| Oedema Peripheral |
3.3% |
| Sepsis |
3.3% |
| Rash |
3.1% |
|
| Interacting |
| Hypertension |
23.4% |
| Hiv Infection |
18.6% |
| Ill-defined Disorder |
13.8% |
| Back Pain |
7.4% |
| Product Used For Unknown Indication |
6.9% |
| Cardiac Failure |
4.8% |
| Migraine |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Lipids Increased |
2.7% |
| Atrial Fibrillation |
2.1% |
| Blood Pressure Increased |
2.1% |
| Diabetic Neuropathy |
1.6% |
| Prophylaxis |
1.6% |
| Arthralgia |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Hypokalaemia |
1.1% |
| Infection Prophylaxis |
1.1% |
| Obesity |
1.1% |
| Anxiety |
0.5% |
| Epilepsy |
0.5% |
|
| Drug Interaction |
16.2% |
| Renal Failure Acute |
13.5% |
| Hyperkalaemia |
10.8% |
| Renal Impairment |
10.8% |
| Blood Creatinine Increased |
8.1% |
| Malaise |
5.4% |
| Cellulitis |
2.7% |
| Coma |
2.7% |
| Decreased Appetite |
2.7% |
| Dehydration |
2.7% |
| Haemoglobin Decreased |
2.7% |
| Headache |
2.7% |
| Hypoglycaemia |
2.7% |
| Intestinal Ischaemia |
2.7% |
| Loss Of Consciousness |
2.7% |
| Metabolic Acidosis |
2.7% |
| Somnolence |
2.7% |
| Urinary Tract Infection |
2.7% |
| Vomiting |
2.7% |
|
